CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction

Diastolic Dysfunction Secondary to Aortic Stenosis Clinical Trial

Status Recruiting

Clinical Trial Summary

The study purpose is to evaluate the safety and feasibility of the CORolla™ TAA in two treatment groups, "CORolla™ Stand-alone group" and " AVR & CORolla™ Add on group".

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Aortic Valve Stenosis
• Diastolic Dysfunction Secondary to Aortic Stenosis
• Diastolic Heart Failure NYHA Class III-IV
• Heart Failure
• Heart Failure, Diastolic

• NCT number: NCT01956526
• Study type: Interventional
• Source: CorAssist Cadiovascular Ltd.
• Contact: Lea Lak, M.D.
• Phone: +972 9 9554500
• Email: lea@corassist.com
• Status: Recruiting
• Phase: N/A
• Start date: August 2013
• Completion date: September 2017